Results 161 to 170 of about 84,355 (327)
Dysregulated Synthesis of Intracellular Type 1 and Type 2 Cytokines by T Cells of Patients with Cutaneous T-Cell Lymphoma [PDF]
, 1999 Bang‐Ning Lee +5 more
openalex +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Background and Objectives Mycosis fungoides (MF) accounts for the majority of cutaneous lymphomas (CL). There is a documented delay in the diagnosis of early‐stage MF. However, its timely diagnosis is paramount to avoid potentially harmful therapies and undue patient distress.
Paula Beatty +7 more
wiley +1 more source
CD4+ cutaneous T-cell lymphomas show the phenotype of helper/inducer T cells (CD45RA-, CDw29+)
, 1989 Wolfram Sterry, Volker Mielke
openalex +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Background and Objectives Dermatological oral antitumor therapeutics (OAT) are often interaction‐prone and used in complex regimens. The pharmacological/pharmaceutical care program of the randomized AMBORA trial significantly improved medication safety with various OAT; however, dermato‐oncological patients were not included.
Lisa Cuba +7 more
wiley +1 more source
Skewed Expression of Activation, Differentiation and Homing-Related Antigens in Circulating Cells from Patients with Cutaneous T Cell Lymphoma Associated with CD7– T Helper Lymphocytes Expansion [PDF]
, 1999 Enrico Scala +6 more
openalex +1 more source
Equine Veterinary Education, EarlyView.Summary Lymphoma in horses is uncommon and rarely diagnosed as a cause of ataxia. This case report describes a 2‐year‐old Standardbred cryptorchid colt who presented with acute onset of grade 3–4/5 spinal ataxia in all four limbs, with the hindlimbs more severely affected than forelimbs and severe proprioceptive deficits.
K. MacMillan +3 more
wiley +1 more source
PI5P4K inhibitors: promising opportunities and challenges
The FEBS Journal, EarlyView.Developing inhibitors is like climbing a steep, challenging mountain. PI5P4K inhibitors hold significant promise for the treatment of cancer, immune disorders, and neurological diseases. However, the path to success is fraught with hurdles, and researchers are therefore required to apply their expertise to overcome critical “checkpoints.” While some ...
Koh Takeuchi +16 more
wiley +1 more source
Incidence trends of primary cutaneous B‐ and T‐cell lymphoma before and after the COVID‐19 pandemic
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Ioannis‐Alexios Koumprentziotis +8 more
wiley +1 more source